Genomic Solutions' ProGest Digestion Station Proteomics is just beginning to reach its potential as a major research tool. Although genomics has dominated the front pages of scientific journals and mainstream media outlets, researchers are quietly discussing the limitations of DNA and molecular biology in describing the behavior of proteins. Keith Ashman, senior research scientist at EMBL in Germany, believes that DNA-based research tools are going to naturally evolve into proteomics. "Genomic
 Genomic Solutions' ProGest Digestion Station |
In the early '90s, protein identification became much easier with advances in mass spectrometry. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) spectrometry and electrospray ionization tandem quadrupole (ESI/MS/MS) are two techniques that have allowed researchers to accurately identify the peptide components of a protein. "Advances in mass spectrometry have allowed proteomics to grow," comments Ashman.
While ...
Memory-enhancing neural networks may also drive involuntary musical loops in the brain.
View this Issue
In this webinar, Brian Hie will discuss Evo2, a state-of-the-art genomic foundation model capable of generalist prediction and design tasks across DNA, RNA, and proteins.
In this webinar, learn how scientists use advanced human brain models to uncover treatment strategies for complex neurological conditions.
Manufacturing cell-based therapeutics requires a robust workflow from start to finish.
Modern DNA synthesis platforms empower researchers to explore the molecular world, from next-generation sequencing to cell and gene therapy development.
This new product line is specifically engineered to meet the rigorous demands of immunology research, vaccine development, animal studies, cell and gene therapy, and therapeutic protein manufacturing.
New fluidics and clog detection systems further simplify operation and reduce instrument downtime
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies
Study identifies new metrics to enhance scRNA-seq based virtual cell modelling
